Plum SEC
Menu
Korean Market
Privacy Policy
Korean Market
Star Rating
Reset (View All)
★★★★★
★★★★
★★★
★★
★
★
★
★★
★★★
★★★★
★★★★★
All Disclosures
Search
PERI
SLSBio (Specialty Lab Solution Bio)
★★★
SLSBio Quarterly Report: Revenue Plunges 45%, Operating Loss Widens, Listing Eligibility Review Poses Risk to Shareholder Value
06/02/2026, 10:31 AM
PERI
SLSBio (Specialty Lab Solution Bio)
★★★
SLS Bio: Q1 2026 Operating Loss of KRW 950M, Under Listing Eligibility Review
05/15/2026, 02:34 PM